-
161
The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
Published 2009-02-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
162
-
163
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
Published 2025-02-01Subjects: “…hepatic arterial infusion chemotherapy (HAIC)…”
Get full text
Article -
164
Unique North American isolates of severe metastatic hypervirulent Klebsiella pneumoniae strain infections with hepatic abscesses seen in young patients within Texas.
Published 2025-01-01“…Within a two-month period, two patients between the ages of 30 to 50 years old presented to a tertiary referral hospital in Texas with septic shock, hepatic abscess, and septic thrombophlebitis. Blood cultures were positive for Klebsiella pneumoniae (isolates 2020CK-00441 and 2021CK-00720 respectively). …”
Get full text
Article -
165
The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
Published 2013-03-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
166
Evaluating the surgical and oncological outcomes of hepatic artery variations in minimally invasive pancreaticoduodenectomy: insights from 2023 data at a high-volume pancreatic center
Published 2025-02-01Subjects: “…Hepatic artery variation…”
Get full text
Article -
167
Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
Published 2014-07-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
168
The effect of nuclear transcriptional factor κВ activation inhibitor – curcumine on the experimental immune liver disease
Published 2010-02-01Subjects: “…experimental immune hepatitis…”
Get full text
Article -
169
Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
Published 2018-08-01“…To estimate efficacy and safety of narlaprevir (NVR) with ritonavir (RTV), pegilated interferon (peg-IFN) and ribavirin (RBV) at treatmentnaïve and earlier treated noncirrhotic patients with chronic hepatitis C caused by the 1st virus genotype in double blind placebo-controlled 3rd phase study (PIONEER). …”
Get full text
Article -
170
Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
Published 2011-06-01Subjects: “…chronic hepatitis c…”
Get full text
Article -
171
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
Published 2025-02-01“…The aim of this study was to assess the feasibility, safety, and efficacy of simultaneous LVD following hepatic arterial chemoembolization (TACE-LVD) before major hepatectomy for hepatocellular carcinoma (HCC).Patients and Methods: A retrospective analysis of the outcomes of 23 HCC patients who underwent TACE-LVD at our center between October 2019 and October 2023 was conducted. …”
Get full text
Article -
172
HВcorAg expression in HВeАg-negative hepatitis: correlation to clinical and histological activity and HВsAg-status
Published 2012-04-01Subjects: “…hвeag-negative hepatitis b…”
Get full text
Article -
173
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
Published 2025-02-01“…Abstract Background The eradication of the Hepatitis C Virus (HCV) reduce the risk of liver cancer (LC), but lifestyle changes after cure may counterbalance its benefit. …”
Get full text
Article -
174
Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis
Published 2025-02-01“…Abstract Hepatic stellate cells (HSCs) transdifferentiate into myofibroblasts during liver fibrosis and exhibit increased glycolysis. …”
Get full text
Article -
175
The Other Side of the Coin: Secondary Takotsubo Syndrome in Living Donor Liver Transplantation Reversul medaliei: sindrom Takotsubo secundar la donator înrudit pentru transplant hepatic
Published 2024-12-01Subjects: “…donator înrudit pentru transplant hepatic…”
Get full text
Article -
176
Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
Published 2023-06-01Subjects: “…hepatitis c…”
Get full text
Article -
177
Putative and pretreatment drug resistance mutations in reverse transcriptase gene among untreated chronic hepatitis B patients at Arifin Achmad Regional District Hospital, Riau, Indonesia
Published 2022-05-01Subjects: “…chronic hepatitis B…”
Get full text
Article -
178
DETECCIÓN DEL GENOMA DEL VIRUS DE LA HEPATITIS E (VHE) EN MUESTRAS DE HECES DE CERDOS EN PLANTAS DE BENEFICIO DE ANTIOQUIA, COLOMBIA
Published 2014-01-01Subjects: “…virus de la hepatitis e…”
Get full text
Article -
179
Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
Published 2025-02-01“…IntroductionDirect antiviral agents (DAAs) have dramatically changed the landscape of liver diseases associated with chronic hepatitis C virus (HCV) infection. However, limited data are available on the antiviral effect of sofosbuvir (SOF) + velpatasvir (VEL) ± ribavirin (RBV), SOF + VEL + voxilaprevir (VOX), and glecaprevir (GLE) + pibrentasvir (PIB) in treating patients infected with HCV GT3 in a real-world setting.MethodsUsing the EMBASE, PubMed, and Cochrane Library databases, articles were screened from 1 January 2016 to 1 June 2024. …”
Get full text
Article -
180